LB-46 in angina pectoris. A critique of anti-anginal drug assessment.
D000319:Adrenergic beta-Antagonists / Q000627:therapeutic use*; D000328:Adult; D000368:Aged; D000787:Angina Pectoris / Q000188:drug therapy* / Q000517:prevention & control; D002986:Clinical Trials as Topic; D004562:Electrocardiography; D005069:Evaluation Studies as Topic; D006339:Heart Rate / Q000187:drug effects; D006801:Humans; D008875:Middle Aged; D010869:Pindolol / Q000627:therapeutic use*; D010919:Placebos; D011433:Propranolol / Q000008:administration & dosage / Q000627:therapeutic use
D000319:Adrenergic beta-Antagonists; D010919:Placebos; D011433:Propranolol; D010869:Pindolol